The late effects of selected immunosuppressants on immunocompetence, disease incidence, and mean life-span. III. Disease incidence and life expectancy.
The effect of various immunosuppressive treatments on mean life-span and disease incidence have been studied. Significant life shortening was seen only in mice which recieved X-irradiation early in life and can be ascribed primarily to an increased incidence of certain malignancies. Marginal life shortening was seen in cyclophosphamide-treated animals, however, survival patterns between those and control animals did not differ until 30 months of age and the magnitude of life-shortening never approached that seen in X-irradiated animals. Thymectomy, splenectomy or cortisone treatment did not alter survival. All immunosuppressive treatments enhanced mortality due to non-neoplastic diseases, however, only a small percentage of animals die with these disease entities. With the exception of cortisone all immunosuppressive treatments increased the incidence of neoplastic disease. However, their effects on various neoplastic processes were variable and unpredictable. Four primary patterns in terms of relative immune competence, disease incidence and life expectancy were seen. Thus, immunodepression may of may not correlate with increased disease incidence, which in turn may or may not have a life-shortening effect. These findings are discussed in terms of the marked reduction of both humoral and cell-mediated immunity normally seen in aged mice and the significance of postulated immune surveillance mechanisms to survival.
D000367:Age Factors; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects / Q000528:radiation effects; D001996:Bronchopneumonia / Q000276:immunology*; D003348:Cortisone / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000494:pharmacology*; D007111:Immunity, Cellular / Q000187:drug effects / Q000528:radiation effects; D007165:Immunosuppression Therapy; D007674:Kidney Diseases / Q000276:immunology*; D008136:Longevity / Q000187:drug effects* / Q000528:radiation effects; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000276:immunology*; D011833:Radiation Injuries, Experimental / Q000276:immunology
D003520:Cyclophosphamide; D003348:Cortisone